Galaxy Oncology Associates Private Limited - Company Profile

It is a healthcare private limited company based in Delhi, Delhi, India, established in 2006.
2006 Delhi, Delhi, India Active
Last Updated:
Access Report
About Galaxy Oncology Associates Private Limited

Galaxy Oncology Associates Private Limited, a active private limited company, was established on 19 October 2006 in Delhi, Delhi, India. Engaging in oncology clinics & cancer treatment within the trade sector, it holds CIN: U85110DL2006PTC154903. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.97 Cr.

It upholds a compliant status. Its leadership includes Sandeep Agarwal (Director), Umang Mithal (Director), Sachin Kumar (Director). Past directors included Arun Kumar Goel, Anand Parkash Sharma, Malay Nandy. It holds ₹11.35 Cr open charges and ₹12.00 Cr settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit No. 302, Third Floor, Plot No. 9, Vardhman Siddhant Plaza, L.S.C. Savita V, Ihar,, Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110DL2006PTC154903

  • Registration Number

    154903

  • Incorporation Date

    19 October 2006

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹4.97 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 4.97 Cr
  • Company Age 19 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 11.35 Cr
  • Satisfied Charges ₹ 12.00 Cr
  • Revenue Growth **** -21.36%
  • Profit Growth **** -1544.49%
  • Ebitda **** -838.21%
  • Net Worth -46.94%
  • Total Assets **** 69.06%
Company report

Galaxy Oncology Associates Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Galaxy Oncology Associates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Galaxy Oncology Associates Private Limited?
Current Directors
Name Designation Appointment Date Status
Sandeep Agarwal Director 20 Aug 2025 Current
Umang Mithal Director 08 Aug 2022 Current
Sachin Kumar Director 29 Dec 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Mar 2017 Past
Pramod Abcsdd Company Secretary 03 Aug 2009 Past
Pramod Abcsdd Managing Director 07 Nov 2006 Past
Pramod Abcsdd Director 08 Aug 2022 Past
Pramod Abcsdd Director 31 Mar 2017 Past
Pramod Abcsdd Additional Director 30 Sep 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Galaxy Oncology Associates.

Galaxy Oncology Associates Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.36% decrease. The company also saw a substantial fall in profitability, with a 1544.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.94%.

Galaxy Oncology Associates revenue growth over time
Galaxy Oncology Associates profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -21.36%
*******
*******
*******
*******
Revenue from Operations
*******
 -17.22%
*******
*******
*******
*******
Total Assets
*******
 69.06%
*******
*******
*******
*******
Profit or Loss
*******
 -1544.49%
*******
*******
*******
*******
Net Worth
*******
 -46.94%
*******
*******
*******
*******
EBITDA
*******
 -838.21%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Galaxy Oncology Associates?

In 2023, Galaxy Oncology Associates had a promoter holding of 50.13% and a public holding of 49.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹113,500,000.00

Satisfied Charges

₹120,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 11.35 Cr
Latest Charge Details
Date Lender Amount Status
29 Oct 2025 Others ₹7.58 Cr Open
01 Feb 2023 Others ₹1.87 Cr Open
20 Sep 2022 Others ₹1.90 Cr Open
15 Dec 2007 Bank Of India ₹12.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Galaxy Oncology Associates?

Unlock and access historical data on people associated with Galaxy Oncology Associates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Galaxy Oncology Associates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galaxy Oncology Associates's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Galaxy Oncology Associates
Recent Activity within the Organization
  • Charges

    The activity A charge with Others amounted to Rs. 7.58 Cr with Charge ID 101201274 was registered on 29 Oct 2025. was completed.

  • Charges

    Progress on A charge with Others of Rs. 1.87 Cr registered on 01 Feb 2023 with Charge ID 100686837 was modified on 24 Sep 2025. was documented.

  • Annual General Meeting

    Galaxy Oncology Associates Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    The activity Sandeep Agarwal was appointed as a Director was appointed as a Director on 20 Aug 2025 & has been associated with this company since 6 months 16 days . was completed.

  • Balance Sheet

    Galaxy Oncology Associates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 1.87 Cr with Charge ID 100686837 was registered on 01 Feb 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Galaxy Oncology Associates Private Limited?

The CIN of Galaxy Oncology Associates Private Limited is U85110DL2006PTC154903.

Where is Galaxy Oncology Associates Private Limited headquartered?

Galaxy Oncology Associates Private Limited is headquartered at Unit No. 302, Third Floor, Plot No. 9, Vardhman Siddhant Plaza, L.S.C. Savita V, Ihar,, Delhi, Delhi, 110092.

When was Galaxy Oncology Associates Private Limited incorporated?

Galaxy Oncology Associates Private Limited was incorporated on 19 October 2006.

Who are the current directors of Galaxy Oncology Associates Private Limited?

The current directors of Galaxy Oncology Associates Private Limited are

What is the primary industry of Galaxy Oncology Associates Private Limited?

The primary industry of Galaxy Oncology Associates Private Limited is Trade.

Is Galaxy Oncology Associates Private Limited a listed company?

Galaxy Oncology Associates Private Limited is unlisted.

What is the capital structure of Galaxy Oncology Associates Private Limited?

The authorized capital of Galaxy Oncology Associates Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.97 Cr.

What is the compliance status of Galaxy Oncology Associates Private Limited?

The compliance status of Galaxy Oncology Associates Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available